Tirads
Tirads
Tirads
TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy
Abstract
Objective: The classification system of the thyroid nodules (TN) TI-RADS (Thyroid Imaging Reporting and Data System)
proposed by Horvath et al. in 2009 is rarely used. The aim of this study was to evaluate a score modified according to
ultrasound (US) criteria for malignancy in order to obtain a better application of this classification in daily practice.
Materials and methods: 3650 TNs were classified according to a score of potential malignancy. US criteria for suspected
malignancy were defined according to published studies and guidelines from various medical international societies.
Each criterion was assigned a point for the final score of malignant probability of the TN. If suspected cervical lymph
nodes were detected, a point was added.
Results: The score in all benign (TI-RADS 2) or probably benign (TI-RADS 3) thyroid nodules was zero. In the TI-RADS
3 group only 2.2% of the TNs were malignant. The scores of TI-RADS 4a, 4b and 4c were one, two and three to four
points, respectively. The malignancy rates were 9.5%, 48% and 85%, respectively. TI-RADS 5 TN had a score of five or
more points with a malignancy of 100% in this study.
Conclusion: A TI-RADS classification based on a score according to the number of suspicious US criteria defined for
malignancy can be applied in daily practice.
2014 Sociedad Argentina de Radiologa. Published by Elsevier Spain, S.L.U. All rights reserved.
Keywords
Thyroid nodule; TI-RADS; Ultrasound; Thyroid scintigraphy
Introduction
138
J. Fernndez Snchez
For TI-RADS assessment, we selected from the PACS imaging archiving system appropriately documented TNs (sagittal
and axial ultrasound images of TNs, obtained by conventional --B mode-- imaging and by color Doppler for the evaluation of perfusion) of which fine needle aspiration (FNA) had
been performed and/or which had been scanned by thyroid
scintigraphy and/or elastosonography and/or other imaging
method (magnetic resonance imaging [MRI], positron emission tomography computed tomography [PET/CT]) and/or
which had undergone histological assessment after surgery
and/or which had at least a one-year clinical follow-up with
ultrasound scans.
As this was primarily a retrospective study, no approval was
requested from the Ethics Committee.
The statistical analysis was based on the calculation of predictive values of the TI-RADS classification categories.
Results
Of the 7960 thyroid ultrasound scans evaluated, one or several TNs were detected in 6127 and no focal lesions were detected in 1833. Of the latter (n = 1833), 1454 cases showed
diffuse abnormality of the thyroid parenchyma, either due
to Hashimotos thyroiditis or to thyroid autoimmune disease
(Grave-Basedow disease), while the remaining 379 patients
with no focal lesion had a normal sized gland, with an ultrasound pattern that was hyperechogenic (in regard to muscle)
and homogeneous, and with normal vascularity on color
Doppler. These normal ultrasound scans of the thyroid, with
an incidence of 4.7% in our series (379/7960 cases) were
classified as TI-RADS 1, similar to BI-RADS classification of the
breast (BI-RADS 1 = normal breast)4,5
Of the 6127 patients with one or several TNs, 1148 met the
study requirements. Of all TNs, 3650 were appropriately documented and had been evaluated by the reference diagnostic
methods. Therefore, they were used for the evaluation of TIRADS classification in this study.
Of these 3650 TNs, 1302 (35.6%) showed benign sonographic features: 73/1302 simple cysts2,17, 104/1302 TNs
with a central cyst (type 1, according to Kim et al classification
for partially cystic TNs)16, 56/1302 TNs with non-interrupted
homogeneous peripheral calcification18 and 1069/1302
spongiform TNs2, 19,20. Based on their ultrasound pattern
and the absence of ultrasound criteria for malignancy, these
TNs had a score of zero. Furthermore, additional tests (FNA [n
= 88] and/or histological examination after surgery [n = 132]
and/or thyroid scintigraphy [n = 585] and/or elastosonography [n = 95] and/or MRI/PET/CT [n = 12] and/or clinical and
sonographic follow-up of at least one year [n = 554] did not
reveal malignancy. Thus, these 1302 TNs were classified as
TI-RADS 2.
The remaining 2194 TNs (60.1%) of the total of 3650 TNs
with no ultrasound criteria for malignancy (score of zero)
appeared as: hyperechoic with or without small cystic abnormalities (527/2194); and solid with peripheral vascularity
and a mixed pattern of hypo, iso or hyperechoic spots and/or
small cystic changes and/or macrocalcifications (1667/2194).
Only 48 (2.2% of 2194) were malignant (histologically confirmed after surgery). In the remaining 2146, additional tests
(FNA [n = 177) and/or histological examination after surgery
[n = 569] and/or thyroid scintigraphy [n = 687] and/or elastosonograhy [n = 128] and/or MRI/PET/CT [n = 18] and/or clinical and ultrasound follow-up of at least one year [n = 843]
did not reveal malignancy. This type of TN was classified as
TI-RADS 3 (i.e., low probability of malignancy).
In turn, 154/3650 TNs (4.2%) were assigned one or more
points of potential malignancy (table 2). One-hundred and
five of those TNs had a score of 1 and 10 of them were malignant (10/105; 9.5%). In 12 of 25 TNs with a score of 2, thyroid carcinoma was histologically detected (12/25; 48%) and
in the case of TNs with a score of 3-4, malignancy increased
up to 85% (12/14).
With the aim of unifying terminology and considering the
malignancy rates published by Horvath et al3 and Kwak et
al6, thyroid nodules were classified as TI-RADS 4a when they
had a score of 1 (malignancy below 10%), as TI-RADS 4b
when they had a score of 2 (malignancy 10-50%) and as TIRADS 4c when they had a score of 3-4 (malignancy 50-85%).
In the remaining 120 TNs with a score of 4, no carcinoma was
detected by the reference methods.
TNs with a score of 5 or higher were classified as TI-RADS 5
(probably malignant, similar to the BI-RADS system). In our
study, these TNs were histologically diagnosed as differentiated thyroid carcinoma (10/10; 100%). Histologically, thyroid
139
TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy
Malignancy
1
2
3-4
5 or higher
10/105 (9.5%)
12/25 (48%)
12/14 (85%)
10/10 (100%)
105
25
14
10
140
PV +
T2/T3 0%
T4a 9.5%
T4b 48%
T4c 85%
T5 100%
PV+: positive predictive value
Discussion
TNs are common. The prevalence of TNs in autopsies ranges
between 8.2 and 64.6%21,22, while detection by ultrasound
has increased from 19% to 68% with the technological development of ultrasound equipment23-25. However, TNs continue
to be difficult to evaluate and this is why there are a large
number of medical guidelines. So much so that, according to
a research literature review conducted on PubMed/Medline for
the preparation of this manuscript, only in the (approximately)
last 10 years, over 250 articles have been published, including
studies, recommendations by medical societies and reviews on
guidelines for the detection of TNs, 9,11,13,14,26-35.
TNs show different ultrasound patterns, with a hypo, iso or
hyperechoic structure which, in turn, may be associated not
only with cystic changes of variable shape and size, but also
with macro and/or microcalcifications. In addition, the margins and shape of TNs may be different.
This diversity (much larger than that of focal lesions in other
organs or glands, such as the liver or breast) poses serious
difficulties for a proper classification.
With the aim of solving this problem, in 2009, Horvath et al3
proposed a classification known as TI-RADS (similar to the system used for breast lesions, BI-RADS)4,5 and later Kwak et al6
added a subtype (4c). However, not all the ultrasound features
of nodules proposed by Horvath et at can be applied with certainty in daily practice6, and as regards Kwak et al, they did not
use TN perfusion on color Doppler within their classification.
Thus, our study also assessed the presence of suspicious cervical lymph nodes (differentiating them from Kwak classification
as regards the evaluation criteria for scoring).
Though quoted in the medical literature, TI-RADS classification is hardly used in daily practice. This may be due,
in the first place, to an unawareness of this system by the
wide range of specialists performing thyroid ultrasound scans
J. Fernndez Snchez
(from family or primary physicians to internists, endocrinologists, surgeons, radiologists and nuclear medicine specialists),
but it may also be attributed to some uncertainty on the part
of the professional performing the US scan (who may be
afraid of misclassifying a TN) or to his/her convenience (as
for some professionals it is easier to report, for example, a
nodular goiter or an enlarged thyroid gland with an hy-
141
TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy
Figure 8 The nodule on Figure 7 corresponds to a toxic adenoma on thyroid scintigraphy with 99mTC-sodium pertechnetate.
142
J. Fernndez Snchez
143
TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy
Figure 13 TI-RADS 4b: nodule with two sonographically suspicious criteria for malignancy: hypoechogenicity and internal
vascularity.
Figure 14 TI-RADS 4c: nodule with microcalcifications, irregular borders and taller than wide shape (greater in its anteroposterior diameter than in its transverse diameter). Score of 3.
Figure 16 TI-RADS 5: hypoechogenic nodule with microcalcifications and poorly defined margins, with perinodular tissue invasion (arrow). Taller than wide shape. Presence of a
cervical lymph node suspicious for malignancy (see: Fig. 17).
Overall score of 6.
144
J. Fernndez Snchez
145
TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy
Conclusion
A TI-RADS classification of TNs based on a score according
to the most relevant sonographically suspicious criteria for
malignancy can be better and more easily applied in daily
practice. Based on the criteria for malignancy and the score
assigned in this study, the probability of malignancy for TNs
with a score of 1 is 10%, while for those with a score of 2 is
almost 50% and for those that have been assigned a score of
3 or 4, the probability of malignancy is 85%. All TNs with a
score of 5 or higher are malignant.
A TI-RADS classification based on the scoring system described above should allow for and lead to unification of terminology and codes for TN classification among all physicians
who evaluate the results of a thyroid ultrasound (whether
they are primary physicians, endocrinologists, radiologists or
specialists in nuclear medicine).
Conflicts of interest
The author declares no conflicts of interest.
References
1. Raggiunti B, Capone F, Franchi A, Fiore G, Filipponi S, Colagrande V,
et al. Ultrasoundelastography: Can it provide valid information for differentation of benign and malignant thyroid nodules? J Ultrasound.
2011;14:136---41.
2. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, et al. Benign and
malignant thyroid nodules: US differentiation --- multicenter retrospective
study. Radiology. 2008;247:762---70.
3. Hovarth E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An
ultrasonogram reporting system for thyroid nodules stratifying cancer risk
for clinical management. J Clin Endocrinol Metab. 2009;94:1748---51.
4. Liberman L, Menell JH. Breast imaging reporting and data system (BIRADS). Radiol Clin North Am. 2002;40: 409---30.
5. Burnside ES, Sickles EA, Bassett LW, Rubin DL, Lee CH, Ikeda DM, et al.
The ACR BI-RADS experience: learning from history. J Am Coll Radiol.
2009;6:851---60.
6. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging
reporting and data system for US features of nodules: a step in establishing
better stratification of cancer risk. Radiology. 2011;260:892---9.
7. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al.
Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Endocrinol Metab. 2002;87:1941---6.
8. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need of biopsy. J Ultrasound
Med. 2004;23: 1455---64.
9. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman
BG, et al. Management of thyroid nodules detected at US: Society of
Radiologists in Ultrasound consensus conference statement. Radiology.
2005;237:794---800.
10. Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, et al.
Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155:27---31.
11. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. American
Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and
Differentiated Thyroid Cancer; Revised American Thyroid Association
management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167---214.
12. Lee MJ, KimEK, Kwak JY, Kim MJ. Partially cystic thyroid nodules on ultra-
146